Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
1234567
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Liver Disease 2017 NIDDK 5R01DK105517-02 Physiologic Consequence of Genetic Variation WATANABE, RICHARD UNIVERSITY OF SOUTHERN CALIFORNIA CA $778,813
Liver Disease 2017 NCI 5R01CA178063-04 Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma RANA, BASABI UNIVERSITY OF ILLINOIS AT CHICAGO IL $331,793
Liver Disease 2017 NCI 5F30CA180731-03 TCR Gene Transfer for Treating HCV-Associated Malignancies SPEAR, TIMOTHY LOYOLA UNIVERSITY CHICAGO IL $49,044
Liver Disease 2017 NCI 5R03CA191978-02 Optimization of radiofrequency ablation with electrically conductive particles KIM, CHARLES DUKE UNIVERSITY NC $79,500
Liver Disease 2017 NIDA 5U01DA040381-02 Cohort Studies on HIV/AIDS and Substance Abuse in Miami BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $1,077,827
Liver Disease 2017 NHLBI 5U01HL121842-02 Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease BYRNE, BARRY UNIVERSITY OF FLORIDA FL $564,323
Liver Disease 2017 NIAID 5R01AI114699-03 Innate immune responses to malaria liver stage infection KAPPE, STEFAN SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $472,500
Liver Disease 2017 NIAID 5R01AI114748-03 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Liver Disease 2017 NIDDK 5F31DK108570-02 Aldehyde Dehydrogenase-2 as a Drug Target for Cholestatic Liver Fibrosis WIMBORNE, HEREWARD MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $40,168
Liver Disease 2017 NHLBI 5R01HL122822-03 Hepatic Wnt/LRP6 Regulation of Plasma Lipids MANI, ARYA YALE UNIVERSITY CT $165,239
Liver Disease 2017 NHLBI 5R01HL119830-03 TTC39B in Metabolism TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Liver Disease 2017 NIAAA 1R01AA024169-01A1 Molecular mechanism of alcohol-associated liver tumor development ZHONG, SHUPING UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Liver Disease 2017 NIDDK 5F30DK105768-03 Roles for FoxO proteins in human liver development HANSEN, KAREN MEDICAL COLLEGE OF WISCONSIN WI $35,483
Liver Disease 2017 NHLBI 5R01HL125649-03 Insulin action, reverse cholesterol transport, and HDL function HAEUSLER, REBECCA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $410,926
Liver Disease 2017 NIAAA 1U01AA024206-01A1 Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver disease FELDSTEIN, ARIEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $341,543
Liver Disease 2017 NIAID 5U01AI115711-03 Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant GRINSPOON, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $685,269
Liver Disease 2017 NCI 5R01CA176001-04 Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis GROSSNIKLAUS, HANS EMORY UNIVERSITY GA $323,700
Liver Disease 2017 NIAID 5R01AI122669-02 Optimization of alpha-hydroxytropolones as novel inhibitors of the HBV RNaseH TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $440,118
Liver Disease 2017 NIEHS 5R01ES022606-04 Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes RUNGE-MORRIS, MELISSA WAYNE STATE UNIVERSITY MI $388,865
Liver Disease 2017 NIAID 5UM1AI069476-10 The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit GRINSZTEJN, BEATRIZ FUNDACAO OSWALDO CRUZ BRAZIL $74,365
Liver Disease 2017 NIDDK 5R01DK105965-02 Molecular and biological functions of miR-29 in lipid homeostasis SETHUPATHY, PRAVEEN UNIV OF NORTH CAROLINA CHAPEL HILL NC $342,000
Liver Disease 2017 NIDDK 5R01DK104893-02 Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis ZHOU, HUIPING VIRGINIA COMMONWEALTH UNIVERSITY VA $390,481
Liver Disease 2017 NIEHS 5R01ES014638-12 Manganese Transport and Toxicity WESSLING-RESNICK, MARIANNE HARVARD SCHOOL OF PUBLIC HEALTH MA $615,473
Liver Disease 2017 NIAID 5UM1AI069418-11 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $2,403,962
Liver Disease 2017 NIDA 5R01DA035146-05 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $550,788
Liver Disease 2017 NCI 5R21CA190945-02 Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma KASEB, AHMED UNIVERSITY OF TX MD ANDERSON CAN CTR TX $208,800
Liver Disease 2017 NIMH 5K24MH097673-05 Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research LETENDRE, SCOTT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $182,619
Liver Disease 2017 NIAID 5UM1AI069503-11 Terry Beirn CPCRA Clinical Trials Unit GORDIN, FRED GEORGE WASHINGTON UNIVERSITY DC $4,875,952
Liver Disease 2017 NIAID 5R01AI103440-05 A molecular basis for control of T cell memory HEDRICK, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $465,000
Liver Disease 2017 NIDA 5P30DA011041-20 5121 Infectious Diseases and Biomedical Core PERLMAN, DAVID NEW YORK UNIVERSITY NY $145,226
Liver Disease 2017 NCI 5R01CA051210-25 Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors ROSS, DAVID UNIVERSITY OF COLORADO DENVER CO $312,983
Liver Disease 2017 NIAAA 5P60AA011605-20 5367 Pilot Projects CREWS, FULTON UNIV OF NORTH CAROLINA CHAPEL HILL NC $60,190
Liver Disease 2017 NCI 5R01CA184456-02 VDAC Regulation of Warburg Metabolism in Hepatocarcinoma MALDONADO, EDUARDO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $341,981
Liver Disease 2017 NIDDK 5R01DK023026-37 Hepatic Organic Anion Uptake and Transport WOLKOFF, ALLAN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $462,393
Liver Disease 2017 NIDDK 5R01DK093774-05 Hepatic Lipid Mobilization by Nuclear Hormone Receptors LEE, YOON-KWANG NORTHEAST OHIO MEDICAL UNIVERSITY OH $296,757
Liver Disease 2017 NIDDK 5K08DK099412-03 The role of macrophage migration inhibitory factor in autoimmune hepatitis ASSIS, DAVID YALE UNIVERSITY CT $152,874
Liver Disease 2017 NCI 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $100,000
Liver Disease 2017 NIAID 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $49,153,075
Liver Disease 2017 NIDA 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Liver Disease 2017 NINDS 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Liver Disease 2017 OD 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $2,899,810
Liver Disease 2017 NIAID 5R01AI110577-03 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $453,213
Liver Disease 2017 NCI 5R01CA030276-35 IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES NIEDERKORN, JERRY UT SOUTHWESTERN MEDICAL CENTER TX $282,171
Liver Disease 2017 NCI 5R03CA201988-02 Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma TSAI, ROBERT TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $74,250
Liver Disease 2017 NIDDK 5R01DK101941-03 Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients GARG, ABHIMANYU UT SOUTHWESTERN MEDICAL CENTER TX $364,500
Liver Disease 2017 NIAID 5UM1AI068632-11 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $20,201,111
Liver Disease 2017 NICHD 5UM1AI068632-11 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $4,567,863
Liver Disease 2017 OD 5UM1AI068632-11 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $96,785
Liver Disease 2017 NIAID 5K08AI102761-05 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $195,063
Liver Disease 2017 NCI 5R01CA202245-02 Biological roles and Mediator-dependent transcription mechanisms of RNA polymerase II(G) ROEDER, ROBERT ROCKEFELLER UNIVERSITY NY $387,731
Liver Disease 2017 NIAID 5R01AI078881-07 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $531,399
Liver Disease 2017 NIAID 5R01AI108765-04 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $514,747
Liver Disease 2017 NCI 5R01CA175380-04 FoxM1 in liver cancer. RAYCHAUDHURI, PRADIP UNIVERSITY OF ILLINOIS AT CHICAGO IL $405,146
Liver Disease 2017 NIDDK 5R01DK105033-02 Novel mechanisms of UPR sensing and nonalcoholic fatty liver disease LI, ZIHAI MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $336,375
Liver Disease 2017 NIBIB 5R37EB001981-16 Magnetic Resonance Elastography EHMAN, RICHARD MAYO CLINIC ROCHESTER MN $397,500
Liver Disease 2017 NIAID 5R01AI104887-05 Control of Viral Pathogenesis by Regulation of 2-5A Levels WEISS, SUSAN UNIVERSITY OF PENNSYLVANIA PA $713,295
Liver Disease 2017 NIAID 5R01AI116943-02 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $545,126
Liver Disease 2017 NCI 5R01CA190209-02 Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy MARKIEWSKI, MACIEJ TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $349,988
Liver Disease 2017 NIDDK 5R01DK063349-12 Transcriptional coactivators and hepatic glucose production WONDISFORD, FREDRIC RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL NJ $345,825
Liver Disease 2017 NIAID 5R01AI116939-03 Carbapenem-resistant bacterial colonization and infection after liver transplant UHLEMANN, ANNE-CATRIN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $572,240
Liver Disease 2017 NIAID 5R01AI085051-08 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $588,464
Liver Disease 2017 NIAID 5R37AI047365-18 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Liver Disease 2017 NIAID 5R01AI050611-13 A chicken model to study hepatitis E virus pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $392,874
Liver Disease 2017 NIDDK 5R01DK105434-02 Investigating Autophagy in GSD-Ia KOEBERL, DWIGHT DUKE UNIVERSITY NC $321,034
Liver Disease 2017 NIDDK 5R01DK104714-02 Role of biliverdin reductase during sterile inflammation in the liver. WEGIEL, BARBARA BETH ISRAEL DEACONESS MEDICAL CENTER MA $391,500
Liver Disease 2017 NIAID 5U01AI115714-03 Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant STOCK, PETER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $621,488
Liver Disease 2017 NCI 5R01CA181658-03 MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors LARSON, ANDREW NORTHWESTERN UNIVERSITY AT CHICAGO IL $449,254
Liver Disease 2017 NIDDK 5R01DK107643-02 Mechanism of SREBP Cleavage Activating Protein Golgi-to-ER Recycling ESPENSHADE, PETER JOHNS HOPKINS UNIVERSITY MD $291,600
Liver Disease 2017 NIDDK 5R01DK102597-03 NAFLD: Mechanisms and Treatments TIMCHENKO, NIKOLAI CINCINNATI CHILDRENS HOSP MED CTR OH $351,000
Liver Disease 2017 NIAAA 1F31AA025278-01 Mechanisms of ethanol-induced dysregulation of gut homeostasis BARR, TASHA UNIVERSITY OF CALIFORNIA RIVERSIDE CA $35,185
Liver Disease 2017 NIDDK 5K23DK095707-05 An Assessment of Liver Disease in HIV-infected and HIV/HBV Co-infected Tanzanians HAWKINS, CLAUDIA NORTHWESTERN UNIVERSITY AT CHICAGO IL $159,184
Liver Disease 2017 NIDDK 5R01DK048252-23 Transgene Persistence in Liver Gene Therapy GROMPE, MARKUS OREGON HEALTH & SCIENCE UNIVERSITY OR $368,829
Liver Disease 2017 NIDDK 5R01DK056621-16 Hepatic autophagy, Stem cells and Fibrosis FRIEDMAN, SCOTT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $381,375
Liver Disease 2017 NCI 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $106,140
Liver Disease 2017 NIMHD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $209,615
Liver Disease 2017 NHLBI 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $286,781
Liver Disease 2017 NIAID 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $1,934,642
Liver Disease 2017 NICHD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $214,936
Liver Disease 2017 NIDA 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $53,072
Liver Disease 2017 NIDCD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $140,046
Liver Disease 2017 OD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $18,901
Liver Disease 2017 NIGMS 5R01GM116898-02 Function and mechanism of the HCV p7 channel and its therapeutic potential CHOU, JAMES HARVARD MEDICAL SCHOOL MA $463,975
Liver Disease 2017 NIDDK 5R01DK107533-02 TIM-3 Negative Costimulation Signaling at the Innate-Adaptive Immune interface in Liver Transplant Ischemia-Reperfusion Injury KUPIEC-WEGLINSKI, JERZY UNIVERSITY OF CALIFORNIA LOS ANGELES CA $346,500
Liver Disease 2017 NIDDK 5R01DK077704-09 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $337,125
Liver Disease 2017 NCI 5R01CA164574-05 Gender Disparity in Bladder Cancer and Chemopreventive Intervention ZHANG, YUESHENG ROSWELL PARK CANCER INSTITUTE CORP NY $325,312
Liver Disease 2017 NHLBI 5R01HL127174-02 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $494,995
Liver Disease 2017 NHLBI 5R01HL127930-02 Molecular Regulation of Apoprotein B Degradation FISHER, EDWARD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $408,678
Liver Disease 2017 NIAID 5K08AI121348-02 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $199,314
Liver Disease 2017 NCI 5R01CA190844-03 Hepatic Stellate Cells and Liver Cancer SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $356,751
Liver Disease 2017 NIAID 5R01AI114630-03 Innate Immune Response to Hepatocyte Death CRISPE, IAN UNIVERSITY OF WASHINGTON WA $521,263
Liver Disease 2017 NIAID 5U01AI104347-05 Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients FENG, SANDY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $941,479
Liver Disease 2017 NHLBI 5K01HL121010-04 The Role of CD8+ T Cells In The Development of Nonalcoholic Fatty Liver Disease KENNEDY, ARION VANDERBILT UNIVERSITY TN $113,004
Liver Disease 2017 NIEHS 2R44ES024644-02A1 Development of high-throughput cardiotoxicity and hepatotoxicity assays with magnetic 3D bioprinting SOUZA, GLAUCO NANO3D BIOSCIENCES, INC. TX $623,123
Liver Disease 2017 NIAAA 5R01AA022986-03 CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease AVADHANI, NARAYAN UNIVERSITY OF PENNSYLVANIA PA $520,771
Liver Disease 2017 NIAAA 5P50AA011999-19 8452 Administrative Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $393,637
Liver Disease 2017 NIAAA 5P50AA011999-19 8464 Animal Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $448,224
Liver Disease 2017 NIAAA 5P50AA011999-19 8465 Mechanisms and Impact of StAR Activation in ALD FERNANDEZ-CHECA, JOSE UNIVERSITY OF SOUTHERN CALIFORNIA CA $164,291
Liver Disease 2017 NIAAA 5P50AA011999-19 8466 Origin and Fate of Myofibroblasts in Alcoholic Liver Disease BRENNER, DAVID UNIVERSITY OF SOUTHERN CALIFORNIA CA $145,215
Liver Disease 2017 NIAAA 5P50AA011999-19 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $206,355
Liver Disease 2017 NIAAA 5P50AA011999-19 8468 Alcohol Abuse and Pancreatic Necrosis PANDOL, STEPHEN UNIVERSITY OF SOUTHERN CALIFORNIA CA $142,020
Liver Disease 2017 NIAAA 5P50AA011999-19 8469 Pilot Project Program TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $120,250
Liver Disease 2017 NIAAA 5U01AA021838-05 Transcriptomics of Liver in Alcoholic Hepatitis NORDEN-KRICHMAR, TRINA UNIVERSITY OF CALIFORNIA-IRVINE CA $255,735
Liver Disease 2017 NIAID 5R21AI122228-02 The impact of quasi-envelopment on hepatitis virus infection and immunity FENG, ZONGDI RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $224,250
Liver Disease 2017 NCI 5R01CA172086-04 PROHIBITIN 1 IN LIVER INJURY AND CANCER LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $312,404
Liver Disease 2017 NCI 5R43CA203351-02 Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS MORGAN, LEE DEKK-TEC, INC. LA $90,362
Liver Disease 2017 NIAID 5F31AI118244-02 Understanding cellular interactions and the immunobiology of the malaria liver stage TWEEDELL, REBECCA JOHNS HOPKINS UNIVERSITY MD $44,044
Liver Disease 2017 NIDDK 5R01DK100425-05 The Role of ChREBP in Fructose Induced Metabolic Disease HERMAN, MARK DUKE UNIVERSITY NC $345,825
Liver Disease 2017 NIAMS 5K23AR063770-05 A rational approach to liver toxicity monitoring in methotrexate users SCHMAJUK, GABRIELA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $137,160
Liver Disease 2017 NIDDK 5R03DK107402-02 Organelle Dysfunction in Liver Inflammation MALHI, HARMEET MAYO CLINIC ROCHESTER MN $79,500
Liver Disease 2017 NIDDK 5R03DK107912-02 Vinyl chloride-NAFLD interaction BEIER, JULIANE UNIVERSITY OF LOUISVILLE KY $77,000
Liver Disease 2017 NIDDK 5R01DK099055-04 Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease PARK, IN-WOO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $333,558
Liver Disease 2017 NIDDK 5R01DK108357-02 Tissue Responses to Metabolic Stress SCHAFFER, JEAN WASHINGTON UNIVERSITY MO $504,247
Liver Disease 2017 NIDDK 5R01DK100319-05 IKKepsilon/TBK1 Inhibitors for the Treatment of Obesity and Type 2 Diabetes SALTIEL, ALAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $592,999
Liver Disease 2017 NCI 5R21CA201963-02 Metabolic Reprogramming of Colon Cancer Liver Metastasis SHEN, XILING DUKE UNIVERSITY NC $172,913
Liver Disease 2017 NCATS 1R21TR001743-01 Targeting glucose metabolism for the treatment of Hepatocellular Carcinoma CHEN, BIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $292,022
Liver Disease 2017 NIGMS 5R01GM103853-05 Cellular Signaling in Drug-induced Toxicity BUMPUS, NAMANDJE JOHNS HOPKINS UNIVERSITY MD $307,800
Liver Disease 2017 NIAID 5R21AI123718-02 Structure and Function of Hepatitis Delta Virus RNA-Protein Complexes CASEY, JOHN GEORGETOWN UNIVERSITY DC $194,375
Liver Disease 2017 NCI 5R01CA183071-04 Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition VIGNERON, DANIEL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $657,802
Liver Disease 2017 NCI 5R03CA182132-02 Inositol-trisphosphate 3-kinase and colorectal cancer cell adhesion GASPERS, LAWRENCE RBHS-NEW JERSEY MEDICAL SCHOOL NJ $79,500
Liver Disease 2017 NIAID 5R01AI116639-03 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Liver Disease 2017 NIDDK 5R01DK068437-12 Postprandial Vitamin A BLANER, WILLIAM COLUMBIA UNIVERSITY HEALTH SCIENCES NY $360,000
Liver Disease 2017 NIAID 5R01AI124006-02 Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines ROBEK, MICHAEL ALBANY MEDICAL COLLEGE NY $399,750
Liver Disease 2017 NIAID 5R01AI123126-02 Integrin-dependent modulation of macrophage function DI PAOLO, NELSON EMORY UNIVERSITY GA $390,000
Liver Disease 2017 NIAAA 5R21AA024387-02 Specific-size hyaluronan in ALD NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $188,219
Liver Disease 2017 NIAID 5R01AI113923-03 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $459,066
Liver Disease 2017 NIDDK 5R01DK107535-03 Regulation of Lipid Storage by mTORC1 BRIDGES, DAVE UNIVERSITY OF MICHIGAN MI $342,157
Liver Disease 2017 NIDDK 5R01DK102791-03 Roles of Neogenin and Matriptase-2 in Hemojuvelin-Mediated Hepcidin Expression ZHANG, AN-SHENG OREGON HEALTH & SCIENCE UNIVERSITY OR $332,264
Liver Disease 2017 NHLBI 5P01HL087123-10 7665 The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance TABAS, IRA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $543,352
Liver Disease 2017 NHLBI 5P01HL087123-10 7666 Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $538,135
Liver Disease 2017 NIAID 5R01AI105035-05 CD4+ T Cells in Acute Versus Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $435,000
Liver Disease 2017 NIAID 5K24AI118591-03 Patient-Oriented Research and Mentorship in HIV and Non-Communicable Diseases KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $152,953
Liver Disease 2017 NIAID 5R01AI116868-02 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $835,913
Liver Disease 2017 NCI 5R01CA102325-11 15-PGDH in Cholangiocarcinogenesis WU, TONG TULANE UNIVERSITY OF LOUISIANA LA $344,269
Liver Disease 2017 NIDDK 5R13DK104611-03 Keystone Symposia Annual Meeting Series on Obesity JARVIS, THALE KEYSTONE SYMPOSIA CO $15,000
Liver Disease 2017 NIAID 5F30AI122721-02 Function of Regulatory T Cells in Tissue Repair FAN, XIYING WEILL MEDICAL COLL OF CORNELL UNIV NY $49,044
Liver Disease 2017 NIDDK 5R01DK054468-14 Mitochondrial Metabolism in Primary Hyperoxaluria HOLMES, ROSS UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $320,166
Liver Disease 2017 NIBIB 2P41EB015908-29 5871 TR&D 3: Imaging Carbohydrate Metabolism MALLOY, CRAIG UT SOUTHWESTERN MEDICAL CENTER TX $643,771
Liver Disease 2017 NIAAA 5R01AA018886-07 The impact of the unfolded protein responses on steatosis SADLER EDEPLI, KIRSTEN NEW YORK UNIVERSITY NY $247,500
Liver Disease 2017 NIA 5R01AG016927-19 The Role of Akt in Cell Survival and Cell Growth HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $455,327
Liver Disease 2017 NIAAA 5K01AA024174-02 Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease PI, LIYA UNIVERSITY OF FLORIDA FL $145,057
Liver Disease 2017 NIDDK 5R01DK102182-03 Stem Cell-Based In vivo Models of Human Genetic Liver Diseases PELTZ, GARY STANFORD UNIVERSITY CA $547,988
Liver Disease 2017 NIDDK 5R01DK062277-14 Role of Beta-Catenin Signaling in Liver Regeneration MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $384,294
Liver Disease 2017 NIAAA 5R01AA023416-04 A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease BUETTNER, CHRISTOPH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $381,375
Liver Disease 2017 NCI 5R01CA190776-03 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $636,729
Liver Disease 2017 NIDDK 5F31DK105714-03 Elucidating the role of Id2a in liver development and regeneration KHALIQ, MEHWISH UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $44,044
Liver Disease 2017 NIAAA 5K23AA023753-03 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $199,800
Liver Disease 2017 NIDDK 5R01DK033765-34 Regulation of Sex Differences in Liver Metabolism WAXMAN, DAVID BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) MA $481,222
Liver Disease 2017 NIDDK 5R01DK081817-07 HCV infection, cross-talk among liver cells, and liver disease progression RAY, RATNA SAINT LOUIS UNIVERSITY MO $340,875
Liver Disease 2017 NIDDK 5K25DK098615-05 Role of SIRT3 in fetal programming and kidney dysfunction JONSCHER, KAREN UNIVERSITY OF COLORADO DENVER CO $130,019
Liver Disease 2017 NIDDK 5R01DK104946-03 Genetic Modifiers Affecting Cellular Injury in Alpha-1-Antitrypsin Deficiency SILVERMAN, GARY WASHINGTON UNIVERSITY MO $343,125
Liver Disease 2017 NIDDK 5K01DK104993-03 Role of LncRNAs in diabetic livers LEUNG, AMY BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $153,576
Liver Disease 2017 NCI 5R01CA193244-07 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $365,750
Liver Disease 2017 NIDDK 5R01DK074932-11 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Liver Disease 2017 NIDDK 5R01DK102170-03 Role of IRF3 in Energy and Glucose Homeostasis ROSEN, EVAN BETH ISRAEL DEACONESS MEDICAL CENTER MA $391,500
Liver Disease 2017 NICHD 5R01HD041230-13 Prenatal Metabolic Programming of the Offspring DEVASKAR, SHERIN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Liver Disease 2017 NICHD 5R01HD075549-04 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $321,437
Liver Disease 2017 NIDDK 1K08DK111397-01 Mentored Clinical Scientist Research Career Development (K08) research grant IBRAHIM, SAMAR MAYO CLINIC ROCHESTER MN $166,956
Liver Disease 2017 NIAAA 5R01AA021390-04 KLF15 and circadian regulation of alcohol-induced liver injury LIN, ZHIYONG CASE WESTERN RESERVE UNIVERSITY OH $356,625
Liver Disease 2017 NIAAA 5R01AA021978-04 Role of ECM and inflammatory remodeling in alcohol-induced liver and lung damage ARTEEL, GAVIN UNIVERSITY OF LOUISVILLE KY $387,696
Liver Disease 2017 NIAID 5R01AI106005-04 Dissecting virus neutralizing determinants to guide HCV vaccine development LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $457,124
Liver Disease 2017 NIDDK 5R01DK038389-29 Lipid transport in the intestine STORCH, JUDITH RUTGERS, THE STATE UNIV OF N.J. NJ $391,908
Liver Disease 2017 NIDDK 5K08DK098623-02 Role of the bile acid activated receptors FXR and TGR5 in Total Parenteral Nutrition associated hepatic and gut disease JAIN, AJAY SAINT LOUIS UNIVERSITY MO $151,632
Liver Disease 2017 NIDDK 5R01DK105099-03 Novel mechanisms stimulating liver repair after acetaminophen overdose LUYENDYK, JAMES MICHIGAN STATE UNIVERSITY MI $339,524
Liver Disease 2017 NIBIB 5R01EB020040-02 Suppression and Analysis of Ultrasonic Clutter During Liver Focal Lesion Biopsy BYRAM, BRETT VANDERBILT UNIVERSITY TN $323,291
Liver Disease 2017 NIDDK 5R01DK028082-35 Metabolic Actions of FGF21 MARATOS-FLIER, ELEFTHERIA BETH ISRAEL DEACONESS MEDICAL CENTER MA $658,162
Liver Disease 2017 NIDDK 5K08DK101603-03 Wnt signaling in hepatocyte homeostasis WANG, BRUCE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $171,778
Liver Disease 2017 NIAID 1R01AI127463-01 Mechanisms of hepatic innate immune activation by HCV GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $556,742
Liver Disease 2017 NIAID 5R01AI123365-02 Structure and function of Hepacivirus envelope glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $625,625
Liver Disease 2017 NIDDK 5R01DK083355-07 Mechanisms of bile duct reprogramming STANGER, BEN UNIVERSITY OF PENNSYLVANIA PA $507,802
Liver Disease 2017 NIDDK 5R01DK108836-02 HDL and Cellular Repair Mechanisms WHITE, C UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $330,750
Liver Disease 2017 NHLBI 1R01HL134853-01 Trib1 regulation of hepatic lipid metabolism and atherogenesis RADER, DANIEL UNIVERSITY OF PENNSYLVANIA PA $402,500
Liver Disease 2017 NIDDK 1R01DK111678-01 Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis ANANIA, FRANK EMORY UNIVERSITY GA $470,998
Liver Disease 2017 NCI 1R01CA211794-01 Role of p62/SQSTM1 in obesity-induced liver cancer KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $739,996
Liver Disease 2017 NIAID 5R01AI095690-07 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Liver Disease 2017 NIDDK 5K08DK101754-04 New Hepatocyte Model Systems to study Hepatitis B Virus Infection SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $159,508
Liver Disease 2017 NIBIB 5R21EB022291-02 Transarterial Immunomodulatory Embolization: A novel approach to cancer therapy AMEER, GUILLERMO NORTHWESTERN UNIVERSITY IL $188,128
Liver Disease 2017 NCI 1UG3CA211232-01 Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer CHILKOTI, ASHUTOSH DUKE UNIVERSITY NC $399,986
Liver Disease 2017 NIDDK 1R01DK111866-01 Fibrocytes regulate liver fibrosis KISSELEVA, TATIANA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $348,750
Liver Disease 2017 NIEHS 1R01ES027488-01 Mechanisms of AHR Metabolic Toxicity RIFKIND, ARLEEN WEILL MEDICAL COLL OF CORNELL UNIV NY $450,765
Liver Disease 2017 NIDDK 1R01DK112034-01 Mechanisms regulating neurotensin secretion and function EVERS, BERNARD UNIVERSITY OF KENTUCKY KY $440,213
Liver Disease 2017 NIAID 1R01AI128074-01 Restoring Immune Tolerance in a Model of Multiple Sclerosis HOFFMAN, BRAD UNIVERSITY OF FLORIDA FL $381,250
Liver Disease 2017 NIAID 5R01AI110358-03 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MED BR GALVESTON TX $387,500
Liver Disease 2017 NCI 5U01CA172320-05 Evaluation of HCC Response to Systemic Therapy with Quantitative MRI TAOULI, BACHIR ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $485,638
Liver Disease 2017 NIDA 5R01DA027379-06 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $485,246
Liver Disease 2017 NIDA 5R01DA016065-14 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $706,777
Liver Disease 2017 NIDA 5U01DA036935-04 HIV Disease Outcomes in Drug Users in Clinical Practice MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $1,496,559
Liver Disease 2017 NIDA 5R01DA012568-19 INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,213,726
Liver Disease 2017 NIDDK 5R01DK083567-08 ROCK1 signaling in glucose metabolism KIM, YOUNG-BUM BETH ISRAEL DEACONESS MEDICAL CENTER MA $391,500
Liver Disease 2017 NCI 1UG3CA211551-01 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $399,914
Liver Disease 2017 NIAID 5R21AI124868-02 Risk of Liver Complications with HBV and HIV Viremia During Tenofovir-Based ART LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $244,615
Liver Disease 2017 NIDDK 5R01DK100301-04 The Fetal Hepatocyte Phenotype and Cell-Based Therapy for Liver Disease SANDERS, JENNIFER RHODE ISLAND HOSPITAL RI $347,446
Liver Disease 2017 NIDDK 5R01DK107498-02 Regulation of lipolysis by mTORC1 KANDROR, KONSTANTIN BOSTON UNIVERSITY MEDICAL CAMPUS MA $386,868
Liver Disease 2017 NIDDK 5R01DK108959-02 The Paracrine Regulation of Mast Cells During Biliary/Cholangiocyte Repair and Damage FRANCIS, HEATHER SCOTT AND WHITE MEMORIAL HOSPITAL TX $170,588
Liver Disease 2017 NIAID 1R21AI127924-01 Ferret cell determinants of hepatitis C virus tropism EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $253,347
Liver Disease 2017 NIAID 5R21AI119499-02 Hepatitis C virus polyprotein processing efficiency regulates infectious virus production TELLINGHUISEN, TIMOTHY SCRIPPS FLORIDA FL $85,215
Liver Disease 2017 NCI 5R01CA188305-03 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $338,538
Liver Disease 2017 NIDDK 5R01DK091538-08 Ketone Body Metabolism and Integrated Metabolic Homeostasis CRAWFORD, PETER SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $251,416
Liver Disease 2017 NIDDK 5R01DK102559-04 Novel transcriptional regulators of bile acid metabolism and hepatotoxicity EDWARDS, PETER UNIVERSITY OF CALIFORNIA LOS ANGELES CA $334,950
Liver Disease 2017 NIDDK 5R01DK101528-03 Cross talk between epithelial, inflammatory and mesenchymal cells in the development of portal fibrosis SPIRLI, CARLO YALE UNIVERSITY CT $374,625
Liver Disease 2017 NIDDK 5R01DK109096-02 Regulation of hepatic lipid accumulation and insulin resistance LIU, JUN MAYO CLINIC ARIZONA AZ $373,500
Liver Disease 2017 NIDDK 5R01DK104770-02 Epigenetic regulation of Wilson Disease MEDICI, VALENTINA UNIVERSITY OF CALIFORNIA AT DAVIS CA $353,250
Liver Disease 2017 NIDDK 5R01DK109102-03 Estrogen and coordinated carbohydrate and lipid metabolism in obesity STAFFORD, JOHN VANDERBILT UNIVERSITY MEDICAL CENTER TN $355,500
Liver Disease 2017 NIDDK 5R01DK102667-03 Innovative Genetic Approaches for Hepatic Repopulation KAESTNER, KLAUS UNIVERSITY OF PENNSYLVANIA PA $360,000
Liver Disease 2017 NIDDK 5R01DK104656-03 LncRNA as a New Mediator of Bile Acid Homeostasis WANG, LI UNIVERSITY OF CONNECTICUT STORRS CT $428,969
Liver Disease 2017 NIDDK 5R01DK105847-04 Bile Diversion: A Simple and Effective Method of Treating Obesity ABUMRAD, NAJI VANDERBILT UNIVERSITY MEDICAL CENTER TN $355,500
Liver Disease 2017 NIAAA 1K99AA025386-01 Altered Treg differentiation in ALD: a novel role for anaphylatoxins C3a and C5a SMATHERS MCCULLOUGH, REBECCA CLEVELAND CLINIC LERNER COM-CWRU OH $110,939
Liver Disease 2017 NIDDK 1K01DK111716-01 Nuclear Receptors as Novel Therapeutic Targets for Wilson’s Disease WOOTON-KEE, CLAVIA BAYLOR COLLEGE OF MEDICINE TX $150,456
Liver Disease 2017 NIAID 5R01AI065256-07 HIV Antiretroviral Therapy and Hepatic Injury SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $549,499
Liver Disease 2017 NIAID 5R01AI111970-04 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,103,751
Liver Disease 2017 NIGMS 5R01GM088076-08 Regulation of drug metabolizing enzymes by miRNAs SKAAR, TODD INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $498,772
Liver Disease 2017 NIAID 1R21AI128325-01 Role of stem cell-derived T lymphocytes in chronic HBV infection SONG, JIM PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $232,950
Liver Disease 2017 NCI 5R01CA185169-04 Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics MCKNIGHT, STEVEN UT SOUTHWESTERN MEDICAL CENTER TX $475,351
Liver Disease 2017 NIA 5R01AG047924-03 Role of Sirtuins in mediating telomere and p53-dependent aging and disease SAHIN, ERGUN BAYLOR COLLEGE OF MEDICINE TX $324,925
Liver Disease 2017 NIEHS 1R21ES027622-01 Functionally maturing iPSC-derived human hepatocytes in 3D microgels KHETANI, SALMAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $240,624
Liver Disease 2017 NIDDK 1R01DK112119-01 Novel Post-Transcriptional Regulators of Lipid Metabolism VALLIM, THOMAS UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Liver Disease 2017 NIAID 5R01AI124680-02 T cell compartmentalization and antiviral response GRAKOUI, ARASH EMORY UNIVERSITY GA $692,917
Liver Disease 2017 NIAID 5R21AI123613-02 Characterization of Plasmodium GAPDH as a candidate for development of a malaria pre-erythrocytic vaccine JACOBS-LORENA, MARCELO JOHNS HOPKINS UNIVERSITY MD $243,000
Liver Disease 2017 NIDA 5K01DA036452-04 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Liver Disease 2017 NICHD 5R21HD087645-02 A model of Alpers Syndrome KIM, SEOK-HYUNG MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $186,875
Liver Disease 2017 NINR 5R01NR016017-02 Symptom burden in End-Stage Liver Disease patient-caregiver dyads HANSEN, LISSI OREGON HEALTH & SCIENCE UNIVERSITY OR $385,000
Liver Disease 2017 NCI 5R01CA083650-15 Altered Growth Factor Pathways in Biliary Cancer SIRICA, ALPHONSE VIRGINIA COMMONWEALTH UNIVERSITY VA $307,269
Liver Disease 2017 NIDDK 5R01DK104998-03 Regulation of Hepatic Gluconeogenesis by the Mitochondrial Pyruvate Carrier TAYLOR, ERIC UNIVERSITY OF IOWA IA $371,737
Liver Disease 2017 NCI 5R01CA118374-09 Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites RYEOM, SANDRA UNIVERSITY OF PENNSYLVANIA PA $342,000
Liver Disease 2017 NIDDK 5F30DK108567-02 The role of SRSF1 in liver function and NASH ARIF, WAQAR UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $49,044
Liver Disease 2017 NCI 5R01CA168912-04 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI AUGUSTA UNIVERSITY GA $320,588
Liver Disease 2017 NIAID 5R03AI119602-02 Identification of cellular factors that mediate HCV cell-to-cell spread UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $75,500
Liver Disease 2017 NIDDK 5R37DK083834-33 Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway MONTMINY, MARC SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $730,528
Liver Disease 2017 NIDDK 5R01DK067215-12 Cellular Mechanisms of Hepatotoxicity. KAPLOWITZ, NEIL UNIVERSITY OF SOUTHERN CALIFORNIA CA $476,495
Liver Disease 2017 NIDDK 5R01DK090311-07 Estrogen Regulation of Hepatic Growth GOESSLING, WOLFRAM BRIGHAM AND WOMEN'S HOSPITAL MA $629,907
Liver Disease 2017 NIDDK 5R01DK099593-04 Function and Mechanism of DDB1-CUL4A E3 Ligase in Liver Lipid Metabolism YIN, LEI UNIVERSITY OF MICHIGAN MI $337,125
Liver Disease 2017 NIDDK 5P30DK097948-03 5070 RESEARCH BASE COMINELLI, FABIO CASE WESTERN RESERVE UNIVERSITY OH $390,368
Liver Disease 2017 NIDDK 5P30DK097948-03 5072 Biorepository Core FIOCCHI, CLAUDIO CASE WESTERN RESERVE UNIVERSITY OH $221,916
Liver Disease 2017 NIDDK 5P30DK097948-03 5073 Histology/Imaging Core PIZARRO, THERESA CASE WESTERN RESERVE UNIVERSITY OH $223,263
Liver Disease 2017 NIDDK 5P30DK097948-03 5742 Mouse Models Core COMINELLI, FABIO CASE WESTERN RESERVE UNIVERSITY OH $227,243
Liver Disease 2017 NHLBI 5R01HL107794-07 Control Sterol and Lipoprotein Homeostasis by miRNA BALDAN, ANGEL SAINT LOUIS UNIVERSITY MO $381,307
Liver Disease 2017 NCI 2R01CA160069-07A1 Hepatic stellate cell regulation of metastatic growth in the liver KANG, NINGLING UNIVERSITY OF MINNESOTA MN $368,125
Liver Disease 2017 NIEHS 4R44ES026464-02 Automation of a Liver Genotoxicity Assay DERTINGER, STEPHEN LITRON LABORATORIES, LTD. NY $450,412
Liver Disease 2017 NIAID 5R01AI117408-02 Enhance AAV Liver Transduction with Capsid Immune Evasion LI, CHENGWEN UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Liver Disease 2017 NCI 5R01CA190144-03 Liver Cancer Risk with rAAV Gene Therapy GROMPE, MARKUS OREGON HEALTH & SCIENCE UNIVERSITY OR $585,925
Liver Disease 2017 NIDCR 5R03DE025652-02 Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease SLADE, GARY UNIV OF NORTH CAROLINA CHAPEL HILL NC $152,000
Liver Disease 2017 NIDDK 5R01DK024031-39 Pathobiology of Hepatic Epithelia LARUSSO, NICHOLAS MAYO CLINIC ROCHESTER MN $473,780
Liver Disease 2017 NIDDK 5R01DK054921-19 Cyclin D1/CDK4 Complex in Hepatocyte Proliferation ALBRECHT, JEFFREY UNIVERSITY OF MINNESOTA MN $351,689
Liver Disease 2017 NIDDK 5R01DK095498-05 Role of Platelet derived growth factor receptor-a in Liver Patho-biology MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $334,950
Liver Disease 2017 NIDDK 5R01DK107405-02 A PSGL-1 Glycopeptide Mimetic for Treatment of Metabolic Syndrome CHAIKOF, ELLIOT BETH ISRAEL DEACONESS MEDICAL CENTER MA $671,542
Liver Disease 2017 NCI 1R03CA212877-01 Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers KELLEY, R. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $79,250
Liver Disease 2017 NIGMS 5R01GM112044-03 Data-Driven Models of the Dynamic Proteome in NAFLD SADYGOV, ROVSHAN UNIVERSITY OF TEXAS MED BR GALVESTON TX $312,660
Liver Disease 2017 NIGMS 5P41GM103314-44 National Resource for Mass Spectrom of Biological Macromolecules CHAIT, BRIAN ROCKEFELLER UNIVERSITY NY $1,617,191
Liver Disease 2017 NIAID 5U19AI111825-04 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $599,480
Liver Disease 2017 NIAID 5U19AI109965-04 5821 Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $407,732
Liver Disease 2017 NIAID 5U19AI109965-04 5825 Protein Purification and Biochemistry DUNCAN, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $328,213
1234567


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer